Find Betahistine Dimesilate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Betahistine mesylate, 54856-23-4, Meginalisk, Merislon, Extovyl, Melopat
Molecular Formula
C10H20N2O6S2
Molecular Weight
328.4  g/mol
InChI Key
ZBJJDYGJCNTNTH-UHFFFAOYSA-N
FDA UNII
X1L0E3R43Y

Betahistine Dimesilate
A histamine analog and H1 receptor agonist that serves as a vasodilator. It is used in MENIERE DISEASE and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers.
1 2D Structure

Betahistine Dimesilate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
methanesulfonic acid;N-methyl-2-pyridin-2-ylethanamine
2.1.2 InChI
InChI=1S/C8H12N2.2CH4O3S/c1-9-7-5-8-4-2-3-6-10-8;2*1-5(2,3)4/h2-4,6,9H,5,7H2,1H3;2*1H3,(H,2,3,4)
2.1.3 InChI Key
ZBJJDYGJCNTNTH-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CNCCC1=CC=CC=N1.CS(=O)(=O)O.CS(=O)(=O)O
2.2 Other Identifiers
2.2.1 UNII
X1L0E3R43Y
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Aequamen

2. Betahistin Al

3. Betahistin Ratiopharm

4. Betahistin Stada

5. Betahistin-ratiopharm

6. Betahistine

7. Betahistine Biphar

8. Betahistine Dihydrobromide

9. Betahistine Dihydrochloride

10. Betahistine Hydrochloride

11. Betahistine Mesylate

12. Betahistine Methanesulfonate

13. Betahistine Methanesulphonate

14. Betaserc

15. Betavert

16. By Vertin

17. By-vertin

18. Dihydrobromide, Betahistine

19. Dihydrochloride, Betahistine

20. Extovyl

21. Fidium

22. Hydrochloride, Betahistine

23. Lectil

24. Melopat

25. Mersilon

26. Mesylate, Betahistine

27. Methanesulfonate, Betahistine

28. Methanesulphonate, Betahistine

29. Pt 9

30. Pt-9

31. Pt9

32. Ribrain

33. Serc

34. Vasomotal

35. Vertigon

2.3.2 Depositor-Supplied Synonyms

1. Betahistine Mesylate

2. 54856-23-4

3. Meginalisk

4. Merislon

5. Extovyl

6. Melopat

7. 2-pyridineethanamine, N-methyl-, Dimethanesulfonate

8. Tenyl

9. Betahistine Methanesulfonate

10. Betahistine Dimesylate

11. Betahistine (mesylate)

12. Methanesulfonic Acid;n-methyl-2-pyridin-2-ylethanamine

13. X1l0e3r43y

14. 2-[2-(methylamino)ethyl]pyridine Methanesulfonate

15. Riptonin

16. Einecs 259-377-7

17. Unii-x1l0e3r43y

18. Tenoxican

19. Suzutolon (tn)

20. 2-(ethylammonio)-n-methylpyridinium Dimethanesulphonate

21. Betahistine Dimethanesulfonate

22. Betahistine Mesilate (jp17)

23. Betahistine Di Mesylate

24. Schembl194604

25. Chembl4303472

26. Chebi:31274

27. Hms2096n07

28. Hms3713n07

29. Hms3886k08

30. Bcp13129

31. Hy-d0237

32. Betahistine Mesilate [mart.]

33. Mfcd00211321

34. S5498

35. Betahistine Mesilate [who-dd]

36. Akos015898737

37. Ccg-220543

38. Ac-23916

39. Betahistine Mesilate [ep Impurity]

40. Betahistine Mesilate [ep Monograph]

41. Db-052657

42. Cs-0010146

43. Ft-0622912

44. D01592

45. D87714

46. N-methyl-2-pyridineethylamine Dimethanesulfonate

47. Bethahistinemethanesulfonate;betahistine Mesilate

48. N-methyl-2-(2-pyridinyl)ethanamine Methanesulfonate

49. Sr-01000722006-3

50. W-105601

51. Q27293318

52. N-methyl-2-(pyridin-2-yl)ethanamine Dimethanesulfonate

53. 2-pyridineethanamine, N-methyl-, Dimethanesulphonate

54. N-methyl-2-(pyridin-2-yl)ethan-1-amine Dimethanesulfonate

55. 2-pyridineethanamine, N-methyl-, Methanesulfonate (1:2)

56. 2-pyridineethanamine, N-methyl-, Methanesulphonate (1:2)

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 328.4 g/mol
Molecular Formula C10H20N2O6S2
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count8
Rotatable Bond Count3
Exact Mass328.07627871 g/mol
Monoisotopic Mass328.07627871 g/mol
Topological Polar Surface Area150 Ų
Heavy Atom Count20
Formal Charge0
Complexity176
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Histamine Agonists

Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically. (See all compounds classified as Histamine Agonists.)


Vasodilator Agents

Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)


API SUPPLIERS

read-more
read-more

01

LEBSA

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLEBSA- Your strategic API source for niche molecules.

Flag Spain
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF ASMF arrow-down AUDIT
Lebsa Company Banner

02

Guangzhou Tosun Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

26th North American ISSX
Not Confirmed
arrow

03

Shouyuan Chemical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

26th North American ISSX
Not Confirmed
arrow

04

IWAKI SEIYAKU

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

26th North American ISSX
Not Confirmed
arrow

IWAKI SEIYAKU

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
26th North American ISSX
Not Confirmed
USDMF CEP/COS JDMF arrow-down EU-WC NDC KDMF VMF Others AUDIT
blank

05

Kanto Chemical

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

26th North American ISSX
Not Confirmed
arrow

Kanto Chemical

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
26th North American ISSX
Not Confirmed
USDMF CEP/COS JDMF arrow-down EU-WC NDC KDMF VMF Others AUDIT
blank

06

Tokuyama Corporation

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

26th North American ISSX
Not Confirmed
arrow

Tokuyama Corporation

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
26th North American ISSX
Not Confirmed
USDMF CEP/COS JDMF arrow-down EU-WC NDC KDMF VMF Others AUDIT
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty